Loading...
XNAS
RSSS
Market cap67mUSD
Oct 08, Last price  
2.03USD
1D
0.50%
1Q
-12.12%
IPO
35.33%
Name

Research Solutions Inc

Chart & performance

D1W1MN
XNAS:RSSS chart
P/E
24.06
P/S
1.41
EPS
0.08
Div yield, %
—
Shrs. gr., 5y
3.77%
Rev. gr., 5y
7.96%
Revenues
48m
-1.53%
12,209,91614,653,37424,935,47333,500,43842,818,54145,498,52636,550,91031,900,14334,363,94525,747,27628,018,44128,793,92231,058,73731,756,34532,934,15237,703,45244,623,89944,623,89949,057,98148,306,957
Net income
3m
+122.99%
-338,321-1,066,041-307,193-5,407,606-6,532,289191,922-1,866,418774,219-497,858-2,293,563-1,678,741-1,174,695-662,242-285,089-1,632,384571,623-3,786,597-3,786,5971,265,5532,822,068
CFO
5m
-24.90%
-932,306233,767352,441-5,093,0211,968,462-95,838310,700-331,895185,171-436,842-605,314576,4462,418,4651,868,406-417,2003,383,8473,550,9543,550,9547,023,1665,274,420

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Research Solutions, Inc., through its subsidiaries, provides research cloud-based software-as-a-service software platform and related services to corporate, academic, government and individual researchers in the United States, Europe, and internationally. It provides Discover Tools that facilitates search discovery across virtually all scientific, technical, and medical (STM) articles available, including basic search solutions and advanced search tools comprising Resolute.ai and Scite.ai products, a tools that allows for searching and identifying relevant research and find insights in other datasets adjacent to STM content, such as clinical trial, patent, life science and medtech regulatory information, competitor and technology landscape insights in addition to searching the customer’s internal datasets. The company also offers Article Galaxy and Article Galaxy Scholar, a solution that allows research organizations to load entitlements, including subscriptions, discount, or token packages, and existing library of articles. In addition, it provides Generative AI, a solution to help researchers understand the quality of the articles they are reviewing, speed up the review process, and to understand how various research papers relate to each other. Further, the company offers references solution, enables researchers to organize literature, collaborate with team members, and access collection of scientific content. Additionally, its platform facilitates the sale of published STM content sold as individual articles. The company was formerly known as Derycz Scientific, Inc. and changed its name to Research Solutions, Inc. in March 2013. Research Solutions, Inc. was incorporated in 2006 and is based in Henderson, Nevada.

Key people

Dave Kutil
Interim Chief Financial Officer, Company Secretary · since 2025
Scott Ahlberg
Chief Operating Officer · since 2013
Sefton Cohen
Chief Revenue Officer · since 2024
Chairman of the Board, President, Chief Executive Officer · since 2025
Barbara Cooperman
Independent Director · since 2022
Independent Director · since 2023
Independent Director · since 2010
Jeremy Murphy
Independent Director · since 2023
Non-Executive Independent Chairman of the Board · since 2023
IPO date
Apr 14, 2009
Employees
131
Domiciled in
US
Incorporated in
US
Legal address
C/O PARACORP INCORPORATED
318 N CARSON ST #208
Carson City, NV 89701
US
Headquarters
15821 Ventura Boulevard
Suite 165
Encino
Los Angeles, CA 91436
US
Previous name
DERYCZ SCIENTIFIC, INC.

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFY
2026‑062025‑062024‑062023‑122023‑062022‑062021‑062020‑062019‑062018‑062017‑06
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT